The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy

Erythropoietin (EPO), a hematopoietic neurotrophin, is a potential therapeutic for Alzheimer’s disease (AD) but has limited blood–brain barrier (BBB) permeability. EPO fused to a chimeric transferrin receptor monoclonal antibody (cTfRMAb) enters the brain via TfR-mediated transcytosis across the BBB...

全面介紹

書目詳細資料

Principais autores:	Joshua Yang, Weijun Ou, Nataraj Jagadeesan, Juste Simanauskaite, Jiahong Sun, Demi Castellanos, David H. Cribbs, Rachita K. Sumbria
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2023-04-01
叢編:	Pharmaceuticals
主題:	Alzheimer’s disease blood–brain barrier erythropoietin microglia molecular Trojan horse monoclonal antibody
在線閱讀:	https://www.mdpi.com/1424-8247/16/4/558
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!